B+
Bull case
20%
Probability
Target price
$0.55
Analysis reference price unavailable
Analysis 2026-08-26 · RankAlpha Sentiment Codex
PDSB
PDS BiotechnologyDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
PDS0301 is now the clear lead asset, allowing scarce capital to be concentrated on a program with encouraging early mCRC and prostate-cancer signals. External funding or partnering could preserve PDS0101 optionality without requiring equivalent internal spending.
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Discontinuation of VERSATILE-003 removes a major development path and makes PDS0301 the principal value driver.
Momentum
78
Value
41
Sentiment
34
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.22 · Bull $0.55 · Bear $0.07Analysis 2026-08-26; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-26 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-10
Investment thesis
As of 2026-09-10
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $4.00
Why
Momentum78 · Δ7d -
Value41 · Δ7d -0.0
Sentiment34 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Sentiment remains the lead driver in the composite.
Contradictions & invalidation
- • Discontinuation of VERSATILE-003 removes a major development path and makes PDS0301 the principal value driver.
- • Limited cash relative to operating losses creates material funding and potential dilution risk.
- • The strategic reset follows weak financial capacity: Q2 cash was $5.6 million, quarterly net loss was $9.8 million, the workforce is being reduced by approximately 36%, the COO departed, and VERSATILE-003 was discontinued.
Catalyst clock
2026-11-24
Execution of PDS0301-focused strategy
Lead driver: Sentiment · See AI snapshot
Momentum
78
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
34
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 77.5 / Value 41.2 / Sentiment 33.5
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-26. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$0.22
Analysis reference price unavailable
Analysis 2026-08-26 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$0.07
Analysis reference price unavailable
Analysis 2026-08-26 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$12.34M
Beta
1.19
Shares Out
55.97M
P/E (TTM) · Derived
-0.3
P/S (TTM)
-
P/FCF (TTM) · Derived
-0.68
Rev YoY
-
EPS YoY
-14.7%
Gross Margin
-
Op Margin
-
Net Debt
-$9.79M
Current Ratio
0.57
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data